ID
11715
Description
This study will compare the effect of a prasugrel 10-mg maintenance dose with a clopidogrel 75-mg maintenance dose on platelet activity, approximately 1 week after the first dose of study drug, in subjects who have been taking clopidogrel 75 mg daily following a percutaneous coronary intervention (PCI) with placement of a stent, performed to treat acute coronary syndrome (ACS). https://clinicaltrials.gov/ct2/show/NCT00356135
Lien
https://clinicaltrials.gov/ct2/show/NCT00356135
Mots-clés
Versions (1)
- 28/07/2015 28/07/2015 -
Téléchargé le
28 juillet 2015
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility SWAP Acute Coronary Syndrome NCT00356135
Eligibility Criteria
- StudyEvent: ODM
Description
Exclusion Criteria
Description
Left main coronary artery stent
Type de données
boolean
Alias
- UMLS CUI-1
- N
Description
left anterior descending (LAD) bifurcation stent
Type de données
boolean
Alias
- UMLS CUI-1
- C3836455
Description
Have any form of coronary revascularization (percutaneous coronary intervention [PCI] or coronary artery bypass grafting [CABG]) planned to occur during the study (from signing consent through the final visit).
Type de données
boolean
Alias
- UMLS CUI-1
- C1532338
Description
Have any form of coronary revascularization (percutaneous coronary intervention [PCI] or coronary artery bypass grafting [CABG]) planned to occur during the study (from signing consent through the final visit).
Type de données
boolean
Alias
- UMLS CUI-1
- C0010055
Description
Receiving or will receive oral anticoagulation (other than aspirin and clopidogrel) that cannot be safely discontinued for the duration of the study.
Type de données
boolean
Alias
- UMLS CUI-1
- C0354604
Description
Receiving or will receive other antiplatelet therapy (other than aspirin and clopidogrel) that cannot be safely discontinued for the duration of the study.
Type de données
boolean
Alias
- UMLS CUI-1
- C1096021
Description
Receiving daily treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) that cannot be discontinued or are anticipated to require daily treatment with NSAIDs during the study.
Type de données
boolean
Alias
- UMLS CUI-1
- C0003211
Description
history of ischemic or hemorrhagic stroke
Type de données
boolean
Alias
- UMLS CUI-1
- C0559159
Description
Intracranial neoplasm
Type de données
boolean
Alias
- UMLS CUI-1
- C1527390
Description
Arteriovenous malformation
Type de données
boolean
Alias
- UMLS CUI-1
- C0003857
Description
Aneurysm
Type de données
boolean
Alias
- UMLS CUI-1
- C0002940
Description
History of transient ischemic attack (TIA)
Type de données
boolean
Alias
- UMLS CUI-1
- C0455536
Description
Have a body weight less than 60 kilograms (kg)
Type de données
boolean
Similar models
Eligibility Criteria
- StudyEvent: ODM